Cardiff Oncology, Inc. Common Stock (CRDF) Stock
NASDAQ · CRDF
Key stats
- Market cap
- $59.54M
- Price / Earnings ratio
- -1.5x
- EPS (TTM)
- -$0.60
- Volume
- Loading
- 52-week high
- $3.31
- 52-week low
- $0.75
Source: third-party data provider, as of November 13, 2026
Compare with CRDF
Recent news

InvestorPlace
Election Year Encore: Can 2020's Top 7 Stock Winners Repeat Their Performance in 2024?
CRDFApril 9, 2024
InvestorPlace
Election Year Encore: Can 2020's Top 7 Stock Winners Repeat Their Performance in 2024?
CRDF

Market Watch
Costco share fall following results, while Cardiff Oncology and MillerKnoll shares soar, and more moving stocks
CRDFSeptember 27, 2023
Market Watch
Costco share fall following results, while Cardiff Oncology and MillerKnoll shares soar, and more moving stocks
CRDF
Technical indicators
- RSI 14
- 33.62
- MACD 12/26/9
- -0.07
- EMA 9 of MACD
- -0.07
- MACD histogram
- -0.00
- SMA 50
- $1.05
- Price below SMA 50
- EMA 50
- $0.98
- Price below EMA 50
- SMA 200
- $1.36
- Price below SMA 200
- EMA 200
- $1.46
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 1 analyst rating
Strong Sell0
Sell0
Hold0
Buy1
Strong Buy0
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Revenue
Net income
Net margin %
2021
2022
2023
2024
2025
8196005409362704680
Debt & Balance Sheet
Total assets
Total liabilities
2021
2022
2023
2024
2025
179M118M59M0
Revenue to Profit
2025$593000.0
Revenue$0.0
Cost of revenue$593000.0
Gross profit$0.0
Operating expenses$-45.9M
Net incomeEarnings
No data available
Source: third-party data provider
Latest news

InvestorPlace
Election Year Encore: Can 2020's Top 7 Stock Winners Repeat Their Performance in 2024?
CRDFApril 9, 2024
InvestorPlace
Election Year Encore: Can 2020's Top 7 Stock Winners Repeat Their Performance in 2024?
CRDF

Market Watch
Costco share fall following results, while Cardiff Oncology and MillerKnoll shares soar, and more moving stocks
CRDFSeptember 27, 2023
Market Watch
Costco share fall following results, while Cardiff Oncology and MillerKnoll shares soar, and more moving stocks
CRDF
About Cardiff Oncology, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees30
CEODr. Mani Mohindru Ph.D.
IPO DateJul 27, 2004
HeadquartersSan Diego, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Mani Mohindru Ph.D. | President, CEO & Director | 1972 |
| Mr. Joshua Muntner BFA, M.B.A. | Chief Financial Officer | 1969 |
| Dr. Ajay Aggarwal M.B.A., M.D. | Chief Operating Officer | — |
| Dr. Roger Sidhu FRCPC, M.D. | Chief Medical Officer | 1976 |
| Ms. Brigitte Lindsay | Chief Accounting Officer | 1969 |
| Dr. Tod Smeal Ph.D. | Chief Scientific Officer | 1965 |
| Ms. Elizabeth Anderson | VP of Finance & Administration | — |
Fundamentals
Valuation
Price-to-sales ratio121.65
Price-to-book value2.33
Profitability
Return on Equity-103.00%
Return on Assets-76.00%
Return on Sales-7884.00%
Gross margin (latest quarter)100.00%
EBITDA$-39.16M
Trading
Average volume400,352
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 33.62
- MACD 12/26/9
- -0.07
- EMA 9 of MACD
- -0.07
- MACD histogram
- -0.00
- SMA 50
- $1.05
- Price below SMA 50
- EMA 50
- $0.98
- Price below EMA 50
- SMA 200
- $1.36
- Price below SMA 200
- EMA 200
- $1.46
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
Analyst consensus:Buy
100% Buy
0% Hold
0% Sell
Analyst price target
- Low
- $9.00
- Average
- $9.00
- High
- $9.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +3.7 | +16.0 | ||||||||||
| 2022 | -47.4 | -24.0 | -7.8 | -46.2 | -6.2 | +78.9 | -5.2 | +38.7 | -45.8 | +4.5 | -0.6 | -5.4 |
| 2023 | +20.9 | +1.2 | -4.1 | +8.1 | -13.4 | -7.0 | +28.3 | -0.5 | -24.9 | -17.7 | +17.1 | +17.5 |
| 2024 | +2.0 | +9.3 | +83.5 | -23.9 | -24.8 | -30.0 | +14.1 | +0.0 | +21.9 | +26.3 | -18.7 | +63.2 |
| 2025 | -5.4 | +5.7 | -17.8 | -10.5 | +25.8 | -6.0 | -32.5 | -20.5 | +5.6 | +13.0 | -1.3 | +29.5 |
| 2026 | -34.2 | +13.5 | -16.5 | +7.5 | +11.1 | -12.2 | -33.3 | +6.5 | +17.5 | -24.6 | -8.3 |
Compare stocks
Market cap
$59.54M
-
-
-
Price / Earnings ratio
-1.50
-
-
-
Price / Sales ratio
121.65
-
-
-
Dividend yield
0.00%
-
-
-
Average volume
400,352
-
-
-
Earnings per share
$-0.60
-
-
-



